Akero Therapeutics, Inc. (NASDAQ:AKRO – Get Free Report)’s stock price gapped up before the market opened on Friday after an insider bought additional shares in the company. The stock had previously ...

"Today, we're not connected enough with nature," explains Olivier Cresp, a master perfumer and co-founder of the fragrance ...

根据提交给美国证券交易委员会的文件显示，Akero Therapeutics, Inc. (NASDAQ: AKRO )首席运营官Jonathan Young近期进行了一笔股票交易。3月12日，Young以每股44.88美元的价格出售了607股普通股，交易总额为27,242美元。此次交易发生之际，AKRO股价在过去六个月内已上涨超过61%。根据 InvestingPro ...

根据证券交易委员会的文件显示，Akero Therapeutics, Inc. (NASDAQ: AKRO )首席科学官Rolph Timothy于2025年3月5日出售了总计12,500股公司股票。每股售价在44.401美元至44.9美元之间，交易总额约为556,590美元。尽管AKRO股票在过去一周下跌11%，但在过去六个月内仍上涨65%。根据 InvestingPro ...

On Thursday, Akero Therapeutics', G. Walmsley Graham, made a $8.79M buy of AKRO, purchasing 200,000 shares at a cost of $43.94 a piece. Akero Therapeutics is trading down about 0.7% on the day Friday.

In this article, we are going to take a look at where Akero Therapeutics, Inc. (NASDAQ:AKRO) stands against other best performing pharma stocks so far in 2025. On February 20, Jared Holz ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In this article, we are going to take a look at where Akero Therapeutics, Inc. (NASDAQ:AKRO) stands against other best performing healthcare stocks so far in 2025. Despite the ongoing craze ...

Jonathan Young, the Chief Operating Officer of $AKRO, sold 607 shares of the company on 03-12-2025 for an estimated $27,242. We received data on the trade from a ...

NEW YORK CITY, NY / ACCESS Newswire / March 23, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...